NUSATRIP INC (NUTR) Fundamental Analysis & Valuation

NASDAQ:NUTR • US67119K1025

Current stock price

9 USD
-0.04 (-0.44%)
At close:
9.03 USD
+0.03 (+0.33%)
After Hours:

This NUTR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NUTR Profitability Analysis

1.1 Basic Checks

  • In the past year NUTR has reported negative net income.
NUTR Yearly Net Income VS EBIT VS OCF VS FCFNUTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 500K -500K -1M -1.5M

1.2 Ratios

  • With a Return On Assets value of 0.41%, NUTR is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.41%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUTR Yearly ROA, ROE, ROICNUTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 10 -10 20 30

1.3 Margins

  • NUTR has a Profit Margin of 3.43%. This is comparable to the rest of the industry: NUTR outperforms 49.63% of its industry peers.
  • Looking at the Gross Margin, with a value of 98.15%, NUTR belongs to the top of the industry, outperforming 99.26% of the companies in the same industry.
Industry RankSector Rank
OM N/A
PM (TTM) 3.43%
GM 98.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NUTR Yearly Profit, Operating, Gross MarginsNUTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NUTR Health Analysis

2.1 Basic Checks

  • NUTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NUTR has about the same amount of shares outstanding.
  • There is no outstanding debt for NUTR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NUTR Yearly Shares OutstandingNUTR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
NUTR Yearly Total Debt VS Total AssetsNUTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 1M 2M 3M 4M

2.2 Solvency

  • NUTR has an Altman-Z score of 4.39. This indicates that NUTR is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.39, NUTR belongs to the top of the industry, outperforming 84.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 4.39
ROIC/WACCN/A
WACC10.39%
NUTR Yearly LT Debt VS Equity VS FCFNUTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 -1M -2M -3M

2.3 Liquidity

  • A Current Ratio of 0.83 indicates that NUTR may have some problems paying its short term obligations.
  • NUTR's Current ratio of 0.83 is in line compared to the rest of the industry. NUTR outperforms 46.67% of its industry peers.
  • NUTR has a Quick Ratio of 0.83. This is a bad value and indicates that NUTR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NUTR has a Quick ratio (0.83) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.83
NUTR Yearly Current Assets VS Current LiabilitesNUTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NUTR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 110.31% over the past year.
  • The Revenue has grown by 64.34% in the past year. This is a very strong growth!
EPS 1Y (TTM)110.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)64.34%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUTR Yearly Revenue VS EstimatesNUTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 500K 1M 1.5M 2M

More info and screens

Find the best growth stocksShow best growing peers

0

4. NUTR Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NUTR Price Earnings VS Forward Price EarningsNUTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 84.44% of the companies in the same industry are cheaper than NUTR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3411.32
NUTR Per share dataNUTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NUTR Dividend Analysis

5.1 Amount

  • No dividends for NUTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NUTR Fundamentals: All Metrics, Ratios and Statistics

NUSATRIP INC

NASDAQ:NUTR (10/8/2025, 8:04:43 PM)

After market: 9.03 +0.03 (+0.33%)

9

-0.04 (-0.44%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap174.42M
Revenue(TTM)2.31M
Net Income(TTM)79.10K
AnalystsN/A
Price TargetN/A
Short Float %6.82%
Short Ratio999.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 75.58
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3411.32
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.12
BVpS-0.1
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 0.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.43%
GM 98.15%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.83
Altman-Z 4.39
F-ScoreN/A
WACC10.39%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)64.34%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y96.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-244.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-203.83%
OCF growth 3YN/A
OCF growth 5YN/A

NUSATRIP INC / NUTR Fundamental Analysis FAQ

What is the fundamental rating for NUTR stock?

ChartMill assigns a fundamental rating of 2 / 10 to NUTR.


What is the valuation status of NUSATRIP INC (NUTR) stock?

ChartMill assigns a valuation rating of 0 / 10 to NUSATRIP INC (NUTR). This can be considered as Overvalued.


What is the profitability of NUTR stock?

NUSATRIP INC (NUTR) has a profitability rating of 1 / 10.


What is the financial health of NUSATRIP INC (NUTR) stock?

The financial health rating of NUSATRIP INC (NUTR) is 3 / 10.